Sonora Quest Collaborates with State and Healthcare Leaders to Significantly Expand COVID-19 Testing Capacity in Arizona

PHOENIX (July 9, 2020) – Governor Doug Ducey announced today a strategic collaboration with Sonora Quest Laboratories, the market share leader in diagnostic laboratory testing in Arizona, the Arizona Department of Health Services (ADHS) and PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, with one goal: expand COVID-19 testing... Read more

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan CARLSBAD, Calif., July 8, 2020 /PRNewswire/ — Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd., a member of the Roche Group, and has applied... Read more

Thermo Fisher Scientific Provides Update to Second Quarter Outlook and Will Hold its Q2 Earnings Conference Call on Wednesday, July 22, 2020

Thermo Fisher Scientific Provides Update to Second Quarter Outlook and Will Hold its Q2 Earnings Conference Call on Wednesday, July 22, 2020 WALTHAM, Mass., July 6, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that, based on currently available information, it estimates that both reported and... Read more

QIAGEN shareholders approve all agenda items related to acquisition by Thermo Fisher Scientific at Annual General Meeting

Venlo, the Netherlands, June 30, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced that its shareholders today approved all agenda items at the Company’s Annual General Meeting related to the proposed voluntary public takeover offer for the acquisition of all ordinary shares in QIAGEN by Quebec B.V., a wholly-owned subsidiary of Thermo... Read more

Waters Extends the Capability and Power of its High-Resolution Mass Spectrometers

Enhancements for the Waters Xevo G2-XS QTof, SYNAPT XS and SELECT SERIES Cyclic IMS Instruments Accelerate Biomedical and Pharmaceutical Research Milford, Mass. – June 23, 2020 – Waters Corporation (NYSE:WAT) announced today a new fragmentation technique and an imaging option for its high-resolution mass spectrometers giving research scientists working across a broad range of end markets... Read more

Waters Introduces the New Arc High-Performance Liquid Chromatograph to Help Laboratories Meet Quality and Production Targets

Modern LC System Replicates Established Test Methods, Delivers Improved Performance; Updates to Lab Business Continuity Solution Also Announced Milford, Mass. – June 23, 2020 – Waters Corporation (NYSE:WAT) today introduced the Waters™ Arc™ HPLC System, a new high-performanceliquid chromatograph (HPLC) for routine testing in the pharmaceutical, food, academic and materials markets. A key target application is... Read more

QIAGEN announces plans to release preliminary Q2 2020 results

Venlo, the Netherlands, June 22, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it plans to provide in the first half of July 2020 an overview of preliminary results for the second quarter and first half of 2020, along with perspectives on anticipated business trends for the third quarter of... Read more